Irving Levin Associates, Inc. Publisher

Reliable and timely business intelligence on M&A and finance in health care and seniors housing

Home | Publications | Resource Center | Database | Free Trials | Conference | Order | Senior Care Blog | Search | Contact Us 1-800-248-1668
 

We will not sell or trade your email--ever.    Privacy Policy

The SeniorCare Investor

July
2007 issue


Carlyle Wins Manor Care Bid-
Its Size Will Only Be Topped By The Sale Of Holiday

After nearly three months in the market, Manor Care reaches an agreement to be purchased by The
Carlyle Group in the largest skilled nursing transaction ever.
...
A New Path For Emeritus-
Stock Offering, Buy-Backs And Large Merger To Close

With a huge stock offering, the re-purchase of 52 facilities in June alone, and the pending merger with Summerville Senior Living, Emeritus is embarking on a new phase in its corporate life.
...
Retirement Housing Market
Prudential closes a large sale, and Assisted Living Concepts buys a large community.
...

Assisted Living Market

We have just a few small transactions in a relatively quiet market (for now).
...
Skilled Nursing Market
A high-end nursing facility in New York was sold, and we are waiting on news of a bankruptcy auction
of a large portfolio in California.
...
Of Unions And Investors
Sunrise Senior Living faces two unruly, but very different, shareholders who are pushing for change.
...

Sign up for a trial subscription and get the current issue!

Read more about The SeniorCare Investor.

Articles Archive

Steve's BLOG on Senior Care

Companies Mentioned in this issue:
July 2007

A
Alvarez & Marsal p11
Apollo Real Estate Advisors p3
Assisted Living Concepts p6
B
Brookdale Senior Living p5
C
Cambridge Investment and Finance Company p10
Cambridge Realty Capital p10
Capital Senior Living p12
Capital Trust p15
Carlyle Group p1
CB Richard Ellis p6, p12
CIT Healthcare Financial Services p15
Collateral Real Estate Capital p14
Collins Realty Group p10
Contemporary Healthcare Capital, LLC p15
E
Emeritus Assisted Living p1
F
Formation Capital p12
Fortress Investment Group p5
G
Genesis HealthCare p2
Genesis HealthCare Corp. p12
GranCare p3
H
Health Care Property Investors p5
Healthcare Finance Group p15
J
JER Partners p12
JPMorgan p1
K
KPMG Peat Marwick p13
L
Landmark Realty Capital p14
Living Centers of America p3
M
Marcus & Millichap p10, p11
Mariner Health p3
Marquette Financial Companies p15
Marquette Healthcare Finance p15
Mather Hospital p10
Mercury Real Estate Advisors p12
Millennium Partners, L.P. p14
N
New South Federal Savings Bank p14
P
Pacifica Sun City p10
Pleasant Care Corporation p11
PRN Capital p15
PRN Marshall Capital p15
Prudential Real Estate Investors p6
R
Renaissance Senior Living p6
S
Saratoga Partners p1
SEIU Master Trust p13
Senior Housing Management p10
Senior Housing Partners II p6
Senior Living Investment Brokerage p8
Sims Mortgage Funding p11
Summerville Senior Living p4
Sunrise Senior Living p11
U
UBS Investment Bank p4
V
Vintage Senior Housing p6
W
Wells Fargo Foothill p15
Z
Ziegler Capital Markets Group p15
Ziegler Healthcare Capital, LLC p15

 

A New Path For Emeritus-
Stock Offering, Buy-Backs And Large Merger To Close

Email Editor

For much of the past 10 years, Emeritus Assisted Living (AMEX: ESC) has been one of the least understood, and least analyzed, companies among its publicly traded seniors housing peer group. And we suspect that was exactly how Dan Baty, the company’s founder and CEO, wanted it to be. Mr. Baty and funds managed by Saratoga Partners have controlled about 65% of the voting stock, so there really was never much room for dissent or outside opinion to shape ESC’s future direction.

Shareholders who invested in the company at its IPO nearly 12 years ago, if they had kept it this entire period, would have had a modest 6.5% annual return. But the real story would have been for those risk-taking investors (or true believers) who bought the stock anytime from late 2000 through late 2003, a period when the share price hit a low of just $0.75, and held on until this year. The annualized returns would range from high double-digits to low triple-digits depending on when you made the purchase. To be fair, the entire seniors housing and care sector was in turmoil during this time period, and practically any investment back then would have reaped outsized returns. Emeritus, however, was often the favorite whipping boy, with very few industry insiders expecting it to surpass $30 per share without posting any profits.

By the end of the first quarter of 2007, when Emeritus announced the acquisition of Summerville Senior Living (SSL), investors sent its shares above $30.00, reaching a high of $39.40 per share in June. We suspect that even Mr. Baty had a little trouble understanding that valuation, and the shares have since declined by 20%. Taking advantage of its lofty valuation, Emeritus completed one of the largest stock offerings ever for a seniors housing or care company in late June, selling a total of 11 million common shares at $31.00 per share, of which 500,000 shares were sold by Saratoga Partners. Saratoga had planned to sell 1.5 million shares in the offering, but since ESC’s share price plunged by almost 18% from the time of the stock offering announcement on June 18 to the pricing, Saratoga probably decided to wait and see if the shares rebounded after the market digested the dilution. The stock offering increased the company’s shares outstanding by 55%, which is an unusually large increase and was one of the causes of the sharp decline in share price. UBS Investment Bank, by the way, was the sole book-running manager for the stock offering.

So what exactly is going on at Emeritus? It is about to complete its largest acquisition ever (Summerville), which will increase the number of units managed by nearly 50% and total revenues by almost 60%; it just completed a huge equity offering which, when combined with the 8.5 million shares that will be issued to Summerville’s owners will double the company’s market capitalization to about $1.2 billion; and it has been engaged in a significant property buy-back program this year. Summerville leases practically all of its facilities, and six months ago Emeritus owned less than 15% of its facilities, which we assume was a strategic decision made years ago when real estate ownership was not seen to be the path to growth for publicly traded companies. That sentiment has changed across the board in the past year or two, and in the first five months of this year, Emeritus purchased 40 facilities from its various landlords. It more than equaled that pace with three transactions in June alone.

In the first transaction, Emeritus has agreed to purchase nine facilities in New York with 711 units that provide assisted living and memory loss services. The price was about $88 million, or $123,800 per unit, plus closing costs, and it is expected to close in the third quarter. Two days later ESC announced the other two property acquisitions. The smaller one involved three facilities in Florida with 431 units that offer assisted living, memory loss and independent living services. The purchase price will be $24.6 million, or just $57,100 per unit. We don’t know why the price was so low, but two of the facilities are part of a cash flow-sharing agreement with Mr. Baty that involves 20 communities.

The final, and largest, deal involves the purchase of 40 facilities with a total of 3,643 units in 19 states from, we believe, Health Care Property Investors (NYSE:HCP), for $482.5 million, or $132,400 per unit. Of the total, 32 facilities with 2,901 units are currently leased by Emeritus, while the remaining eight with 742 units are leased by Summerville, but will all be owned by Emeritus once the merger between the two companies is completed, which should be any day in July. Once the transaction with Summerville is completed and all of these property buy-backs are closed, Emeritus will own just over 40% of its facilities. Most of the proceeds from the stock offering will go towards these property acquisitions, which totaled $595.1 million in just three days. This is a new Emeritus.

When the dust settles and all the transactions close as scheduled, the "new" Emeritus will operate more than 285 facilities with about 24,400 units and annualized revenues of about $725 million. For the first quarter of 2007, Emeritus had a GAAP loss of almost $10 million, and after the Summerville acquisition and property buy-backs, the loss will still be close to that. The big difference, however, is the actual cash flow and cash flow per share. The "previous" Emeritus would have had net cash flow for 2007 of about $20 million, or just over $1.05 per share. But the "new" Emeritus will have annualized net cash flow of almost $60 million, or more than $1.50 per share.

These numbers are rough estimates and do not even incorporate any synergies with the merger and general increases in occupancy and operating cash flow, but they show the power of selling stock at a high multiple, buying back leases and not worrying about a $40 million increase in depreciation. We suppose they can thank Fortress Investment Group (NYSE: FIG) for this strategy with Brookdale Senior Living (NYSE: BKD), which just increased its dividend to an annual rate of $2.00 per share, and current yield of 4.4%, despite continuing to lose money on a GAAP basis. Emeritus hasn’t stated that they plan to start issuing dividends, but if the dividend tax rate remains at 15%, we could see a dividend rate of $0.50 to $0.75 per share, especially if ESC’s operating fundamentals continue to improve. This is all speculation on our part, but it makes sense and also seems to fit in with our assumption that Dan Baty will ease himself out of the "co-CEO" title and hand the job over to Summerville’s Granger Cobb and become chairman emeritus (we just had to use that one again).

FREE TRIAL TO THE
SENIORCARE
INVESTOR
!

If you like this article, there’s lots more waiting for you in The SeniorCare Investor. It’s the bible of what's going on in senior care M&A today.

Sign up for two free months right now! There’s no obligation, no writing “cancel” on a bill. Happy reading!

The SeniorCare Investor

First Name


Last Name

Company

Company Type

Address


Address2


City


State


ZipCode


Country


Email


Email (again, to verify)


Phone


Fax

To confirm this request please enter: trsci


Submission may take a few seconds. Please click only once.

Like this article? Sign up below for a FREE TRIAL to The SeniorCare Investor.

Back to top

 

 

Irving Levin Associates, Inc.,  268 1/2 Main Avenue, Norwalk, CT 06851
800-248-1668; 203-846-6800
203-846-8300 fax

general@levinassociates.com

Since 1948, Irving Levin Associates, Inc. has been the leading source of information and investment research on mergers and acquisitions in the Behavioral Health Care, Biotech, e-Health, Home Health Care, Hospitals, Laboratories, MRI and Dialysis, Long Term Care, Managed Care, Medical Devices, Pharmaceuticals, Physician Medical Groups, Rehabilitation and other health care markets.

More Irving Levin Information:
Mergers, Acquisitions and Healthcare Venture Capital Financing Research at Irving Levin Associates | Dealmakers Resource Center on Senior Care and Health Care Companies | Healthcare Marketing Research and Healthcare Finance Publications | Database of Healthcare Ventures, Mergers and Acquisitions | Free Trial Request For One Of Our Newsletters Customer Service at Irving Levin Associates | Publication Order Form | Press Room| Contact Us
 

© 1995-2008, Irving Levin Associates, Inc. All rights reserved.